Sarah Gaffey
Foundation Medicine (United States)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Brain Metastases and Treatment, Immune cells in cancer
Most-Cited Works
- → Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma(2019)1,356 cited
- → Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma(2020)246 cited
- → Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial(2019)150 cited
- → Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma(2015)130 cited
- → Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma(2014)117 cited
- → Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results(2021)86 cited
- → Barriers to accrual and enrollment in brain tumor trials(2019)77 cited
- → Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma(2019)77 cited
- → A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy(2016)61 cited
- → Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas(2014)60 cited